Uihlein Richard E bought GALT
July 31, 2026 · Form 4 insider transaction
Uihlein Richard E bought 31,825,235 shares of Galectin Therapeutics Inc. at $3.00 per share, a transaction worth $95.48M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
31,825,235
Price
$3.00
Total value
$95.48M
InsiderUihlein Richard E
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 31, 2026
Filing dateAugust 4, 2026
Shares owned after42,162,911
OwnershipIndirect
10b5-1 planNo
AmendedNo